RAILY AESMED (02135) announced its interim results for the six months ended June 30, 2025. The group recorded revenue of HK$84.598 million, representing a decrease of 27.99% year-on-year. Loss attributable to owners of the parent company was HK$7.57 million, an increase of 368.15% compared to the same period last year. Loss per share was 1.36 cents.

During the reporting period, the company's medical aesthetic services revenue was approximately HK$74.9 million, down about 9.7% from approximately HK$83 million for the six months ended June 30, 2024. The decline was attributed to the fact that increased average spending per customer could not offset the impact from a decrease in active customer numbers due to intense industry competition, resulting in reduced revenue from minimally invasive aesthetic services and dermatology beauty services.